Yuyu Pharma Inc (000227) — Cash Flow-to-Debt Ratio
Yuyu Pharma Inc (000227) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of ₩836.62 Million could theoretically repay 0% of its total liabilities (₩63.32 Billion) in one year. Explore Yuyu Pharma Inc (000227) long-term investment share to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Yuyu Pharma Inc Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Yuyu Pharma Inc across 11 annual periods. Also explore 000227 total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Yuyu Pharma Inc (2014–2024)
Year-by-year debt coverage analysis for Yuyu Pharma Inc. For market capitalisation and broader financial context, see 000227 market cap.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.34x | ₩24.95 Billion | ₩72.62 Billion | ▲ +6255.6% |
| 2023 | 0.01x | ₩420.86 Million | ₩77.86 Billion | ▲ +106.2% |
| 2022 | -0.09x | ₩-6.23 Billion | ₩71.83 Billion | ▼ -223.7% |
| 2021 | 0.07x | ₩4.51 Billion | ₩64.30 Billion | ▲ +199.5% |
| 2020 | -0.07x | ₩-2.67 Billion | ₩37.86 Billion | ▼ -125.2% |
| 2019 | 0.28x | ₩13.19 Billion | ₩47.17 Billion | ▲ +121.2% |
| 2018 | 0.13x | ₩6.11 Billion | ₩48.35 Billion | ▲ +770.2% |
| 2017 | 0.01x | ₩561.35 Million | ₩38.66 Billion | ▼ -95.1% |
| 2016 | 0.30x | ₩9.82 Billion | ₩33.01 Billion | ▲ +177.9% |
| 2015 | -0.38x | ₩-11.68 Billion | ₩30.60 Billion | ▼ -937.8% |
| 2014 | 0.05x | ₩1.36 Billion | ₩29.91 Billion | — |